Progyny Inc (NASDAQ: PGNY) kicked off on Monday, up 2.46% from the previous trading day, before settling in for the closing price of $15.45. Over the past 52 weeks, PGNY has traded in a range of $13.93-$42.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 61.75%. While this was happening, its average annual earnings per share was recorded 0.00%. With a float of $76.48 million, this company’s outstanding shares have now reached $95.73 million.
Let’s determine the extent of company efficiency that accounts for 566 employees. In terms of profitability, gross margin is 22.08%, operating margin of 6.28%, and the pretax margin is 7.48%.
Progyny Inc (PGNY) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Progyny Inc is 15.28%, while institutional ownership is 91.54%. The most recent insider transaction that took place on Jul 16 ’24, was worth 270,900. In this transaction PRESIDENT of this company sold 9,030 shares at a rate of $30.00, taking the stock ownership to the 362,583 shares. Before that another transaction happened on Jun 28 ’24, when Company’s Director sold 1,462 for $28.39, making the entire transaction worth $41,506. This insider now owns 10,098 shares in total.
Progyny Inc (PGNY) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.16 earnings per share (EPS), higher than consensus estimate (set at 0.12) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.00% per share during the next fiscal year.
Progyny Inc (NASDAQ: PGNY) Trading Performance Indicators
Take a look at Progyny Inc’s (PGNY) current performance indicators. Last quarter, stock had a quick ratio of 2.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.26. Likewise, its price to free cash flow for the trailing twelve months is 8.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.63, a number that is poised to hit 0.14 in the next quarter and is forecasted to reach 0.71 in one year’s time.
Technical Analysis of Progyny Inc (PGNY)
Looking closely at Progyny Inc (NASDAQ: PGNY), its last 5-days average volume was 1.62 million, which is a jump from its year-to-date volume of 1.38 million. As of the previous 9 days, the stock’s Stochastic %D was 13.82%. Additionally, its Average True Range was 0.72.
During the past 100 days, Progyny Inc’s (PGNY) raw stochastic average was set at 11.52%, which indicates a significant decrease from 28.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.81% in the past 14 days, which was lower than the 78.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.19, while its 200-day Moving Average is $28.83. However, in the short run, Progyny Inc’s stock first resistance to watch stands at $16.00. Second resistance stands at $16.16. The third major resistance level sits at $16.35. If the price goes on to break the first support level at $15.65, it is likely to go to the next support level at $15.46. Now, if the price goes above the second support level, the third support stands at $15.30.
Progyny Inc (NASDAQ: PGNY) Key Stats
The company with the Market Capitalisation of 1.43 billion has total of 95,221K Shares Outstanding. Its annual sales at the moment are 1,089 M in contrast with the sum of 62,040 K annual income. Company’s last quarter sales were recorded 304,090 K and last quarter income was 16,490 K.
